Pfizer

Pfizer is grappling with 'a world of hurt' following its Covid triumph. The company faces mounting pressure due to sliding vaccine revenues and fears that it overpaid for new drugs. This combination of financial issues puts significant stress on boss Albert Bourla.

Pfizer reported adjusted earnings of 77 cents per share, exceeding expectations, and increased its full-year revenue forecast to between $60.5 billion and $62.5 billion.

Pfizer exceeded quarterly revenue estimates due to strong performance from non-Covid products and raised the lower end of its revenue guidance. However, the company reduced its full-year revenue forecast for Covid products to $4 billion from $5 billion.

Andy Cohen expressed outrage over Rand Paul's criticism of Anthony Fauci but did not mention Cohen's past collaboration with Pfizer to promote the Covid vaccine. The article highlights Cohen's selective focus on the issue.

A class action against manufacturers of decongestant medications containing phenylephrine was partially revived by the Second Circuit after the FDA mandated their labels state effectiveness, despite plaintiffs' claims they are no better than a placebo. The court upheld most dismissals but allowed claims about false 'maximum strength' advertising and unclear FDA approval processes to proceed.

A cancer drug, daraxonrasib, developed by Revolution Medicine, nearly doubled survival rates for pancreatic cancer, sparking a standing ovation at a conference. The article highlights the U.S. innovation model, the 'Innovation Treadmill,' which balances high drug prices with rapid generic substitution to sustain medical breakthroughs. It contrasts U.S. drug access with European delays and discusses trends like genetic advancements and AI in biotech.

Arkansas Attorney General Tim Griffin sued pharmaceutical companies including Johnson & Johnson, Eli Lilly, Pfizer, and AstraZeneca, alleging they conspired to block healthcare providers from accessing discounted drugs under the 340B federal program. The companies are accused of imposing restrictive requirements to limit the use of contract pharmacies, which covered entities rely on to serve underserved communities.

President Donald Trump announced a plan to impose 100% tariffs on generic drugs starting August 2028, increasing to 200% in 2029, aiming to reshape pharmaceutical production in the U.S. The administration has not yet issued a formal order, while brand-name drug tariffs remain unchanged. Exemptions and lower rates apply to companies building U.S. plants and certain trade partners.

The Centers for Disease Control and Prevention awarded Pfizer contracts worth $1.24 billion for COVID-19 vaccines in fiscal 2026 and 2027. Republican leaders may face political risks from this decision.

A week after two columns at the former Pfizer headquarters in New York City buckled, causing multiple floors to collapse and mass evacuations, the focus is on recent developments and the building's future. The incident occurred at 235 East 42 St., leading to significant structural damage.

MetroLoft, a developer involved in converting an old Pfizer office building, has multiple projects with construction-related violations, according to city records. The developer lists four active Manhattan projects, including 111 Wall St. and 767 Third Ave.

Nike is hiring David M. Denton as its new CFO, offering a $7.25 million cash award and other incentives. Denton has prior CFO experience at Pfizer, Lowe’s, and CVS Health. Nike’s recent quarterly results show flat revenue and declining gross margins amid strategic challenges.

A buckled support beam at a New York construction site halted work on a major office-to-housing conversion project, underscoring engineering challenges in adaptive reuse. The project aims to convert two midtown Manhattan office buildings, one built in 1909 and another in the 1960s, into 1,600 apartments by adding stories and redesigning structures.

The buckling of two steel columns at the former Pfizer headquarters in Manhattan has raised questions about one of the nation’s largest office-to-apartment conversions.

A dispute involving the Pfizer vaccine has impacted air traffic agencies in Poland and Romania. The article references a Pfizer research and manufacturing site but provides no further details on the nature of the dispute.

Crews have stabilized a high-rise building that caused evacuations, though restricted areas remain during the investigation. The 37-story former Pfizer building is undergoing conversion to residential apartments.

A 37-floor high-rise in midtown Manhattan remains blocked off after columns buckled, prompting evacuations and stabilization efforts. Officials confirm the structure is stable, with temporary shoring installed on floors 18-23. The building, formerly Pfizer's headquarters, is being converted into a 1,600-unit luxury apartment as part of a national trend of office-to-residential conversions.

Residents and hotel guests in Manhattan were gradually allowed to return to cordoned streets after an under-construction high-rise showed structural instability, prompting evacuations and street closures. Mayor Zohran Mamdani confirmed the building is stable, but four nearby buildings remain under evacuation orders. Construction workers protested the use of non-union labor at the site.

Two columns buckled in the former Pfizer headquarters building in New York City, leading to street closures and evacuations, but the building did not collapse. The incident caused chaos for dozens of people in the area.

A high-rise under construction in Manhattan experienced structural issues, leading to evacuations and street closures. Officials stabilized the building, but some surrounding areas remain under evacuation orders. The developer, MetroLoft, attributes the damage to added weight from construction.

A partially constructed Manhattan high-rise buckled and sagged, leading to evacuations and street closures. The building has been stabilized, but some evacuations and closures remain as repairs continue. The developer attributes the damage to added weight from construction.

Crews stabilized a Manhattan high-rise under construction after columns buckled and floors sagged, leading to evacuations and street closures. The building, former Pfizer headquarters, remains under repair with some surrounding areas still evacuated. MetroLoft, the developer, attributes the damage to added weight from expanding the top floors.

An under-construction Manhattan high-rise stabilized after columns buckled, leading to lifted evacuations of nearby buildings. Emergency repairs are ongoing at the former Pfizer headquarters, now being converted into luxury apartments.

Crews are working to stabilize the former Pfizer headquarters in New York City after it was deemed structurally unsafe due to buckling support columns. Video footage shows steel bending and a slight lean in the high-rise, raising concerns of potential collapse.

An unstable building in Midtown Manhattan has caused multiple evacuations and street closures. The structure is the former Pfizer headquarters being converted into apartments.

FDNY drone images revealed buckled structural columns and damage inside a Midtown construction site, leading to evacuations and concerns about a localized collapse beneath a 10-story horizontal expansion of the Pfizer building.

Roads in Midtown Manhattan were closed due to a partial collapse of the former Pfizer building on 42nd Street, leading to a 'frozen zone' restricting traffic from 40th to 45th Street and First to Third Avenues, affecting at least 10 buildings.

The Pfizer building in Midtown Manhattan partially collapsed on Tuesday, leading to evacuations. Mayor Zohran Mamdani reported that the structure has not moved in two hours and is beginning to stabilize.

An under-construction high-rise in Manhattan remains unstable after columns buckled and floors sagged, leading to ongoing evacuations. The building, a former Pfizer headquarters being converted to luxury apartments, is still moving, prompting evacuations of nearby buildings including a school.

A 37-story building in Midtown NYC was evacuated along with seven surrounding buildings due to a safety breach causing the structure to shift and risk localized collapse. The building, located on East 42nd Street, was previously the Pfizer headquarters.

A Manhattan high-rise under construction near the Chrysler Building and Grand Central Terminal remains unstable after bricks fell and columns buckled, forcing evacuations of nearby buildings. The 1970s-era former Pfizer headquarters, being converted to luxury apartments, showed structural issues on floors 21-26 with no reported injuries.

The old Pfizer building in Manhattan, being converted into a residential development, has a history of violations. It was evacuated after structural issues caused floors 21-26 to collapse.

Reports of falling bricks and buckling columns at a Midtown Manhattan high-rise under conversion to luxury apartments forced evacuations, including a nearby school with 400 children. No injuries were reported, and city officials confirmed inspections at the 38-story former Pfizer headquarters. The building's structural issues prompted street closures and ongoing safety assessments.

Falling bricks and buckling columns at a Midtown Manhattan high-rise prompted evacuations, including a school with 400 children. The building, formerly Pfizer's headquarters, is being converted to luxury apartments. No injuries were reported, and officials emphasized safety as the priority.

Evacuations were ordered at a 33-story building under construction in Midtown Manhattan after structural beams on the 21st floor began buckling, causing upper floors to sag and bricks to fall. The incident disrupted public transportation and led to evacuations of adjoining buildings, though no injuries were reported.

Bricks fell from a Manhattan high-rise at 235 East 42nd Street, leading to evacuations and the discovery of buckled columns and sagging floors. No injuries were reported, and all construction workers were accounted for. The building, former Pfizer headquarters, is being converted into a residential rental development.

Protillion Biosciences hired Robert Hollingsworth as chief scientific officer. He previously held the same role at Shoreline Therapeutics and worked at Pfizer as vice president and chief scientific officer of cancer vaccines and immunotherapeutics.

Pfizer and Valneva plan to seek approval for a new Lyme disease vaccine, following the failure of a 1990s vaccine due to lawsuits and public fear. A survey of hunters, a high-risk group for tick exposure, found mixed reactions, with some expressing interest and others seeking more information about safety and effectiveness.

Clive Meanwell, chairman of Population Health Partners, leveraged a competitive bidding war between Pfizer and Novo Nordisk for obesity startup Metsera, which reached a $10 billion offer. He now focuses on AI-driven solutions to address large-scale health challenges through innovative technologies and business models.

Nike appointed David Denton, a former Pfizer executive, as its new CFO amid restructuring efforts. Olive and Alder Co., a natural skincare brand, will host a pop-up at Perkins Rowe. OpenAI restricted the initial release of its GPT-5.6 model to government-approved partners due to U.S. scrutiny.